A* protein of bacteriophage φX174 carries an oligonucleotide which it can transfer to the 3−OH of a DNA chain  by van Mansfeld, A.D.M. et al.
Volume 150, number 1 FEBS LETTERS December 1982 
A* protein of bacteriophage 4x174 carries an oligonucleotide 
which it can transfer to the 3 ‘-OH of a DNA chain 
A.D.M. van Mansfeld, H.A.A.M. van Teeffelen, J. Zandberg, P.D. Baas, H.S. Jansz, 
G.H. Veeneman+ and J.H. van Boom+ 
Institute of Molecular Biology and Laboratory for Physiological Chemistry, State University of Utrecht, Padualaan 
8, 3584 CH Utrecht and +Department of Organic Chemistry, State University of Leiden, 2300 RA Leiden, 
The Netherlands 
Received 28 September 1982 
The bacteriophage 9X174 gene A encodes two proteins: gene A protein and A* protein. Purified A* 
protein acts as a single-stranded, DNA-specific endonuclease which remains covalently attached to the 
5’-end of the cleavage site. Incubation of A* protein with the synthetic heptamer CAACTTG or with 
oligonucleotides which yield this heptamer after cleavage with the A* protein yields oligonucleotides with 
the sequences CAACTTGAG, CAACTTGAGG and CAACTTGAGGA. This indicates that A* protein 
carries an oligonucleotide with the sequence -AG, -AGG or -AGGA. The oligonucleotide can be 
transferred to the 3’-end of the heptamer CAACTTG. This suggests that A* protein reacts with a specific 
DNA sequence in the infected cell. 
Bacteriophage 4x174 A * protein DNA-protein complex Synthetic oligonucleotide 
DNA-ligating activity 
1. INTRODUCTION 
The DNA replication of bacteriophage dX174 
depends on the replication machinery of the host 
and only one viral gene, gene A. Gene A encodes 
two proteins, gene A protein and A* protein [l]. 
Gene A protein is a multifunctional protein in the 
DNA replication of 4X [2]. Among others it trig- 
gers the rolling circle replication by cleavage of the 
viral strand of the supercoiled double-stranded 
replicative form DNA (RFI) at a specific site, the 
origin [3]. At the end of one replication round gene 
A protein cleaves and ligates the viral DNA strand 
such that a circular unit length molecule is 
produced. 
’ The role of the second protein specified by gene 
A, the A* protein, is so far unknown. It is syn- 
thesized from an internal translational start within 
gene A, in the same reading frame as the gene A 
protein. It thus lacks the N-terminal part (- %rd of 
the polypeptide chain) of the gene A protein. 
However, experiments with purified A* protein 
have shown that it has retained some of the en- 
zymatic activities of the gene A protein (see [4,5]). 
A* protein cleaves, like gene A protein, single- 
stranded #X viral DNA at the origin, but also at 
other sites [6]. A* protein and gene A protein re- 
main covalently attached to the 5 ‘-end of the 
cleavage site. A* protein can ligate DNA [7,8]. 
The synthetic hexadecadeoxyribonucleotide 
CAACTTGATATTAATA, which corresponds to 
nucleotides 4299-4314 in the #X DNA sequence 
[9], is cleaved next to the G-residue by gene A pro- 
tein. This site corresponds to the cleavage site of 
gene A protein in RF DNA 131. A* protein cleaves 
the hexadecamer at the same site but additional 
products are observed [lo]. Here, we report that 
the additional products are the result of a transfer 
of oligonucleotides with the sequence AG, AGG or 
AGGA, respectively, to the heptamer CAACTTG. 
The oligonucleotides occur covalently linked to the 
A* protein in the A* protein preparation. They are 
presumably remnants of a DNA sequence which is 
cleaved intracellularly by the A* protein. 
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2. MATERIALS AND METHODS 
2.1. Enzymes 
$X A* protein was purified from 4X174 
am3-infected Escherichia coli C cells as in [7]. 
Snake venom phosphodiesterase (SVD) and 
bacterial alkaline phosphatase (BAPF) were from 
Worthington (Freehold NJ), proteinase K from 
Merck (Darmstadt), TCinduced polynucleotide 
kinase from Boehringer (Mannheim), and terminal 
transferase from Enzo Biochem. Inc. (New York 
NY) 32P-Labelled A* protein was purified follow- 
ing the same procedure as for A* protein from a 
0.5 1 culture of E. coli C in dephosphorylated 3XD 
medium [ 1 l] that had been infected with 4X am3 
in the presence of 10mCi [32P]orthophosphate 
(Amersham). 
2.2. Protein electrophoresis 
The final step in the purification of 32P-labelled 
A* protein was a gradient elution from a 
heparin-Sepharose column [7]. Fourty fractions 
of 550~1 were collected. The protein of 200~1 of 
one fraction was precipitated with trichloroacetic 
acid, dissolved and subjected to electrophoresis as 
in [12] on 12.5% polyacrylamide gel. After elec- 
trophoresis the gel was stained with silver as in 
[13]. Then the gel was dried and radioactive bands 
were visualized by autoradiography. Treatment 
with alkali was performed as follows. Protein was 
precipitated with trichloroacetic acid, the 
precipitate was washed twice with 400~1 ethanol/ 
ether (1: 1) and once with 100~1 ethanol/ether 
(1: 3). The precipitate was dried, dissolved in 50~1 
0.1 M KOH and incubated for 3 h at 37°C. Then 
the protein was analyzed on a gel as above. 
2.3. The synthetic hexadecadeoxyribonucleotide 
The characterization of the synthetic hexade- 
cadeoxyribonucleotide (hexadecamer) CAACT- 
TGATATTAATA was described in [lo]. It was 
labelled at the 5 ‘-end using [Y-~~P]ATP (2000 
-3000 Ci/mmol; Amersham) and T4 polynucleo- 
tide kinase following the protocol in [ 141. The hex- 
adecamer and ATP were separated by 
chromatography over a Sephadex G-50 column. 
2.4 Incubation with A * protein 
In a standard assay 1.5ng A* protein is in- 
cubated with 0.015pmol labelled hexadecamer in 
104 
1OmM Tris-HCl (pH7.6), 1 mM EDTA, 5mM 
MgC12, 5 mM DTT, 150 mM NaCl, 2% glycerol in 
16~1 for 30min at 37°C. The reaction is stopped by 
the addition of 1.5~1 100mM EDTA (pH 8.0) and 
incubation for 30min at 37°C with 1~1 of a solu- 
tion of 5 mg proteinase K/ml 1 mM Tris (pH 7.5), 
0.1 mM EDTA that had been preincubated for 
30min at 37°C. The samples were analyzed on a 
25% polyacrylamide gel as in [IO]. 
2.5. Isolation of the products after incubation 
of hexadecamer with A * protein 
5 ’ -Labelled hexadecamer (1.5 pmol) was in- 
cubated with 300ng A* protein in the above buf- 
fer, in 400~1 for 30min at 37°C. Then 40,~l 
1OOmM EDTA (pH 8.0) and 25~1 of 5 mg pro- 
teinase K/ml, 1 mM Tris-HCl (pH7.6) and 
0.1 mM EDTA that had been pre-incubated for 
30min at 37°C were added. After 30min at 37°C 
this mixture was extracted with an equal volume of 
phenol. After separation the phenol phase was ex- 
tracted with 50~1 Hz0 and the combined water 
phases were extracted with ether. The sample was 
diluted with Hz0 to 1.5 ml and applied to a small 
DEAE-cellulose (Whatman DE52) column that 
had been packed in a blue Eppendorf tip and had 
been washed twice with 1 ml 2M NHdHCO3 and 3 
times with 1 ml 0.1 M NHdHCOj. The radioactive 
oligonucleotides bound to the DEAE-cellulose. 
The column was washed 3 times with 0.5 ml 0.1 M 
NHdHCO3 and the radioactive material was eluted 
with 4 times 0.1 ml 2 M NH4HCO3. The samples 
were dried at 37°C the residue was dissolved twice 
in 50~1 Hz0 and dried again. Then the samples 
were dissolved in 20~1 H20, mixed with 20,ul 98% 
formamide, 1OmM NaOH, 0.05% bromophenol 
blue, 0.05% xylenecyanol F, heated and applied to 
a 25% polyacrylamide gel as above. 
After electrophoresis the radioactive bands were 
excised and the oligonucleotides were eluted as in 
[14]. The eluates (1 ml) were diluted to 5 ml with 
Hz0 applied to a small DEAE column, washed and 
eluted. Water and the volatile salt were removed as 
described above. Finally, the samples were dissolv- 
ed in 50~1 H20. 
2.6. Sequence analysis of the oligonucleotides 
The oligonucleotides obtained by the above pro- 
cedure were digested partially by incubation at 
37°C with 200pg SVD in 1OmM Tris-HCl 
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(pH 7.6), 1 mM EDTA, 5 mM MgClz in 30~1. At 1, 
10 and 30min samples were taken and added to 
phenol to stop theleaction. Suitable samples were 
mixed and subjected to two-dimensional separa- 
tion; i.e., high-voltage electrophoresis at pH 3.5 on 
a cellulose acetate strip and after transfer of the 
oligonucleotides to a DEAE thin-layer, chroma- 
tography with a 3% ‘homomix’ [15]. 
The radioactive products were detected by 
autoradiography. One of the oligonucleotides was 
also subjected to the chemical method for sequenc- 
ing DNA [ 141, which was carried out exactly as in 
[lOI* 
3. RESULTS 
Fig. 1 shows the reaction products obtained after 
incubation of the 5 ’ -1abelled hexadecamer 
CAACTTGATATTAATA with A* protein. 
Besides the heptamer CAACTTG some other pro- 
ducts are present. Based on its mobility in the urea- 
m* 
7 
Fig. 1. Incubations of A* protein with the hexadecamer, 
the heptamer and lO* product, autoradiograph after gel 
electrophoresis: hexadecamer without (a) and with A* 
protein (b); heptamer without (c) and with A* protein 
(d); the lO* product without (e) and with A* protein (f). 
containing polyacrylamide gel the predominant ex- 
tra product has an apparent length of 10 
nucleotides. It was therefore called the lO* pro- 
duct. Two other products which are present in far 
lower amounts migrated as a nonamer and an 
undecamer and were called 9* and 1 1*, respective- 
ly. The 9*, lO* and 1 l* products could be 
dephosphorylated by alkaline phosphatase and 
elongated by terminal transferase with an efficien- 
cy comparable to the 5 ’ -1abelled hexadecamer (not 
shown). This and the fact that they can be digested 
with SVD (see below) indicates that the 9*, lO* and 
1 1 * products have free 5 ’ -terminal phosphate and 
free 3 ’ -hydroxyl groups. 
The 9*, lO* and 1 l* products were isolated and 
nucleotide sequences were determined. This was 
done by partial digestion from the 3 ‘-end with 
SVD and separation of the digestion products in 
the two-dimensional system following the 
‘mobility-shift’ method (fig. 2). The sequence of 
the lO* product was confirmed by the procedure in 
1141. 
The sequences are compared with the sequence 
of the starting hexadecamer in table 1. 
Table 1 
The sequences of the oligonucleotides 
Hexadecamer CAACTTGATATTAATA 
Heptamer CAACTTG 
lo*, major extra product CAACTTGAGG 
9*, minor extra product CAACTTGAG 
1 1*, minor extra product CAACTTGAGGA 
Surprising are the sequences -AG, -AGG and 
-AGGA at the 3 ’ -ends of the 9*, lO* and 1 1 * pro- 
ducts, respectively. The starting hexadecamer does 
not contain the sequence -AG, -AGG or 
-AGGA, so the oligonucleotide material with 
these sequences must have been added with 
another component of the incubation mixture; i.e., 
the A* protein preparation. The final steps in the 
purification procedure of A* protein are a 
DNA-cellulose column, followed by a dialysis and 
an heparin-Sepharose column (71. If free 
oligonucleotide material was present after the 
DNA-cellulose column this would probably have 
been lost by the dialysis and subsequent column 
chromatography. As a consequence -AG, -AGG 
105 
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Fig. 2. Mobility shift analysis of lo*, 9* and ll* products (a, b and c, respectively) Electrophoresis was from the left 
to the right and chromatography was ascending. Starting from the first nucleotide, the nucleotide that causes the shift 
to the next longer product has been indicated. 
ng A* protein 
Fig. 3. The amounts of hexadecamer, heptamer and lO* 
product after incubation of the hexadecamer with vary- 
ing amounts of A* protein; the hexadecamer was in- 
cubated with different amounts of A* protein for 
60min. The products were analyzed by gel elec- 
trophoresis. After autoradiography the relative amounts 
of the products were calculated by excising the bands 
corresponding to the hexadecamer, the lO* product 
(together with the 9* and 11* product) and the heptamer, 
and determining the radioactivity; 100% is the sum of 
the radioactivity of the 3 bands; (U) relative 
amount of hexadecamer; (ti) relative amount of 
heptamer; (o---a) relative amount of lO* product. 
Fig. 4. SDS-polyacrylamide gel analysis of A* protein 
purified from cells infected with phage in the presence of 
“P: A* protein stained; (b) autoradiograph of the same 
lane. 
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and -AGGA must be present bound to the protein. 
This suggests that A* protein can be ‘*P-1abelled 
via the oligonucleotide. Therefore, we isolated A* 
protein from cells that had been infected with 
phage in the presence of [32P]phosphate. Purified 
A* protein was analyzed on a SDS-polyacryl- 
amide gel, the gel was stained to localize the A* 
band. An autoradiograph of the dried gels shows 
a radioactive band at the position of A* protein 
(fig. 4). A sample of the A* preparation was 
treated with alkali as in section 2 and analyzed on 
a gel. After the incubation with alkali radioactive 
material still comigrates with the A* protein. This 
indicates that the 32P was not present as phosphate 
esterified to serine residues since this band is alkali 
labile. 
So phosphate-containing material, possibly 
oligonucleotides, occurs firmly bound to a protein 
that migrates at the position of A* protein. 
The sequences of the 9*, lO* and ll* products 
suggest that -AG, -AGG and -AGGA are 
transferred to the heptamer CAACTTG, which is 
generated by cleavage of the hexadecamer by A* 
protein. This transfer indeed takes place, for in an 
incubation of purified heptamer with A* protein 
lO* was produced (fig. 1). Formation of lO* pro- 
duct in an incubation of A* protein with the hep- 
tamer CAACTTG also shows that the transfer is 
not necessarily coupled to the cleavage reaction. 
Cleavage and transfer can proceed in two separate 
steps. Fig. 3 shows how much IO* is formed after 
60min incubation of the hexadecamer with five 
different amounts of A* protein (a constant por- 
tion of 20% of the hexadecamer seems not to be 
nicked). The amount of IO* product increases if 
more A* protein is added. Concomitantly, the 
amount of heptamer decreases. Some of the lO* 
product can, on its turn, be cleaved by A* protein 
and yields the heptamer. This is shown by incuba- 
tion of purified lO* product with A* protein (fig. 
1). 
4. DISCUSSION 
In incubations of purified A* protein with the syn- 
thetic hexadecamer CAACTTGATATTAATA, 
a heptamer with the sequence CAACTTG, a 
decamer CAACTTGAGG (lo* product) and, to a 
lower extent, a nonamer CAACTTGAG (9* pro- 
duct) and an undecamer CAACTTGAGGA (1 1* 
product) are generated. The heptamer is formed by 
cleavage next to the G-residue. The presence of the 
IO* product (and 9* and 1 1*) can be explained by 
assuming that the A* protein preparation contains 
oligonucleotide material with the sequences 
(predominantly) -AGG and also -AG and 
-AGGA, which are transferred to the heptamer, 
CAACTTG. In analyses of incubations of A* pro- 
tein with 5 ’ -1abelled single-stranded DNA frag- 
ments, the bands representing the cleavage pro- 
ducts are often accompanied by bands that migrate 
slightly slower. The positions of these bands cor- 
respond to an increase in length of about three 
nucleotides (unpublished). 
The lO* product arises mainly if a large amount 
of A* protein is added. Together with the observa- 
tion that lO* can also be generated by incubation 
of the purified heptamer with A* protein, this in- 
dicates that lO* is formed in two steps: 
(1) Cleavage of the hexadecamer which yield the 
heptamer; 
(2) Transfer of the oligonucleotide to the 
heptamer. 
The role of the A* protein during the q5X infec- 
tion cycle is unknown. Possibly it is concerned with 
the shut off of the host DNA synthesis [ 17-191. 
The presence of oligonucleotides in the A* protein 
preparation is a new observation that may be the 
trace to the function of A* protein. Therefore it is 
important to know how the oligonucleotide(s) that 
can be transferred is (are) present and whether they 
are derived from host DNA or from viral DNA. 
Free oligonucleotides would have been lost during 
the purification procedure so they probably occur 
bound to the protein. Possibly the oligonucleotides 
occur covalently bound to the A* protein. This is 
supported by the observation of a radioactive band 
at the position of A* protein in an experiment in 
which A* protein was isolated from cells that had 
been infected with 4XX am3 phage in the presence 
of 32P. In vitro A* protein binds covalently to the 
5 ‘-end after cleavage of the DNA [6,16]. So the 
oligonucleotides which are carried by A* protein 
may indicate an earlier cleavage by A* protein. 
Since divalent cations, which are essential for the 
cleavage activity, are trapped by adding EDTA, A* 
protein cannot nick during the isolation procedure. 
So the A* molecules that carry an oligonucelotide 
have nicked DNA in a previous stage; i.e., in the 
infected cell. 
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The sequences of the oligonucleotides that are 
transferred, predominantly -AGG, but also -AG 
and -AGGA, demonstrate that previous cleavage 
and binding takes place with a high specificity. 
Possibly -AG, -AGG and -AGGA are the rem- 
nants of a same, longer DNA fragment that has 
been broken down by unspecific nucleolytic events. 
In vitro the sequence -CTTACTTGAGGA- 
(nucleotides 983-994 in the complete 4X sequence 
[9]) in @X single-stranded viral DNA is efficiently 
cleaved next to the first G-residue by A* protein 
[ 161. Cleavage in vivo at this site would yield A* 
protein bound to DNA with the sequence AGGA. 
There is no experimental evidence that this occurs. 
At the moment, we do not know whether the 
oligonucleotides are derived from host DNA or 
from viral DNA. Since the answer to this question 
will shed light on the function of A* protein, this 
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